Kelly Schick
Personalreferent bei C4 THERAPEUTICS, INC.
Vermögen: 326 046 $ am 30.04.2024
Aktive Positionen von Kelly Schick
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| C4 THERAPEUTICS, INC. | Personalreferent | 12.01.2021 | - |
ScripNet LLC
 ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Corporate Officer/Principal | - | - |
Karriereverlauf von Kelly Schick
Ehemalige bekannte Positionen von Kelly Schick
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2011 | - |
| AMAG PHARMACEUTICALS, INC. | Personalreferent | 01.09.2016 | - |
Ausbildung von Kelly Schick
| Boston University | Undergraduate Degree |
| The Curtis L. Carlson School of Management | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 2 |
| Human Resources Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Technology Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Kelly Schick
- Erfahrung
